496785-25-2

Upstream product

• 100-63-0 phenylhydrazine 
• 1698-53-9 4,5-dichloro-1-phenylpyridazin-6-one 
• 1193-02-8 4-aminotiophenol 

Downstream Products

• 1268514-99-3 C₂₉H₃₀Cl₂N₃O₄PS 
• 1268514-81-3 C₂₉H₃₁ClN₃O₄PS 
• 1268514-87-9 C₂₉H₃₀ClFN₃O₄PS 
• 1268514-93-7 C₃₀H₃₃ClN₃O₅PS 
• 1268514-97-1 C₂₉H₃₀Cl₂N₃O₄PS 
• 1268514-95-9 C₂₇H₂₆Cl₂N₃O₄PS 
• 1268514-79-9 C₂₉H₃₁ClN₃O₄PS 
• 1268514-77-7 C₂₇H₂₇ClN₃O₄PS 
• 1268514-85-7 C₂₉H₃₀ClFN₃O₄PS 
• 1268514-83-5 C₂₇H₂₆ClFN₃O₄PS 
• 1268514-91-5 C₃₀H₃₃ClN₃O₅PS 
• 1268514-89-1 C₂₈H₂₉ClN₃O₅PS 

Relevant academic research and scientific papers

Synthesis and antiviral activities of α-aminophosphonate derivatives containing a pyridazine moiety

The title compounds (4) were obtained by the reaction of 2-phenyl-4-chloro-5-(4-amin ophenyl)pyridazin-3(2H)-one, aldehydes, and O,O′-dialkyl phosphite under reflux conditions using dry toluene as a solvent. The preliminary bioassays indicate that the synthesized compounds have moderate to good against tobacco mosaic virus (TMV) activity. It was found that compound 4b had a good inactivation effect in vivo against TMV, with an inhibition rate of 81.0%. Copyright Taylor & Francis Group, LLC.